Lixte Biotechnology Holdings Announces New Appointment to Board of Directors

ohn S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc. announces the appointment of Mel Sorensen, M.D. to the company’s Board of Directors.
Dr. Sorensen is currently Board Director, President and Chief Executive Officer of Ascenta Therapeutics. He is a highly experienced leader and administrator in cancer therapeutics and cancer drug [...]

The nursing of the Navigators will provide the emotional issues patients

A Pro-Celebrity Pro-Am Tennis & Golf Tournament — Benefiting the Tim & Tom Gullikson Foundation auctions dozens of items and experiences to raise funds for care and support programs for brain-tumor patients and their families. Through the generosity of one of Swingtime’s sponsors, Allen Systems Group (ASG), Swingtime has been provided with two tickets to [...]

Efforts, Events Seek To Improve Health Of Pacific Islanders

The following summarizes coverage of events and initiatives that seek to reduce racial and ethnic health disparities.
* Choctaw Nation of Oklahoma: The Substance Abuse and Mental Health Services Administration has awarded the Choctaw Nation of Oklahoma American Indian tribe a three-year, $1.5 million grant to go toward residential substance use treatments [...]

MiddleBrook Pharmaceuticals, Inc. focused on developing and commercializing novel anti-infective products

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK – News), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that MiddleBrook President and CEO John Thievon will be presenting at the Rodman & Renshaw 10th Annual Healthcare Conference at the New York Palace Hotel in New York City on Nov. 11, 2008, at 12:00 [...]

TAITRA Announces that Medical Tourism & Health Centers Meet Together in Taiwan

The population of aging and overweight is increasing rapidly recently followed by more intensive prevention and treatment demands for chronic diseases. Meanwhile, the general public is also realizing the importance of prevention medicine is not only reshaping healthcare service content but also placing extra demand for new medical treatment. Taiwan, in particular, leads other countries [...]

Innovative Devices and Futuristic Therapies

Clinical investigators at today’s “Innovative Devices and Futuristic Therapies” session during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, presented 12-month follow-up data from the ATLANTA Trial. The results include zero percent thrombosis in patients discontinuing dual anti-platelet therapy after only 30 days.
The ATLANTA Trial is a first-in-man [...]

Edwards Lifesciences’ New Transcatheter Heart Valve Data Demonstrate Positive Results

Edwards Lifesciences Corporation, the world leader in the science of heart valves, announced that new data from two studies of the Edwards SAPIEN transcatheter aortic heart valve with the RetroFlex transfemoral delivery system were presented today at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
The 30-day results from [...]

Nursing application guide

The bibliographic database, PsycINFO, produced by the American Psychological Association, has a great deal to offer researchers, faculty, students, and professionals in a wide range of disciplines. PsycINFO serves as an invaluable finding tool for psychology and the behavioral sciences.
Nurses, healthcare professionals, and clinical researchers have discovered the value of PsycINFO for research in a [...]

U.S. Department of State Taps IBM to Extend Telemedicine’s Reach to Remote Regions of Pakistan

Munir is five years old, and he lives in a ruggedly remote, rural village in Northern Pakistan. For months, he has suffered from an aggressive and worsening skin lesion that, for want of medical care, has gone untreated. But now, his fortunes have changed for the better — as they have for a growing number [...]

Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease

An early proof-of-concept study presented today shows promising results for imatinib mesylate in the treatment of pulmonary arterial hypertension (PAH), a severe, incurable blood vessel disorder.
Preliminary findings from a 59-patient, multi-center Phase II clinical trial suggest imatinib mesylate provides a treatment benefit, as demonstrated by a significant improvement in pulmonary vascular resistance and a numerical [...]